Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation

• Published in: Infection and drug resistance 2024-06, Vol.17, p.2249-2260
• Main Authors: Kamel, Noha A, Abdalla, Mahmoud S, Al Ali, Amer, Alshahrani, Mohammad Y, Aboshanab, Khaled M, El Borhamy, Mervat I
• Format: Article
• Language: English
• Subjects: Beta lactamases; cre; Cytomegalovirus infections; Drug resistance in microorganisms; Egypt; Epstein-Barr virus; esbls; Escherichia coli; Health aspects; Hematopoietic stem cells; Infection; Medical research; Medicine, Experimental; Methicillin; Mortality; mrsa; Original Research; Pathogenic microorganisms; Posaconazole; pre-engraftment infections; pre-transplant screening; Staphylococcal infections; Stem cells; Transplantation
• ISSN: 1178-6973; 1178-6973
• DOI: 10.2147/IDR.S463868

Owing to the rising incidence of multidrug-resistant organisms (MDRO) and the high mortality rates associated with such bacterial infections post-hematopoietic stem cell transplantation (HSCT), we investigated the MDRO colonization rate prior to transplantation using an active surveillance approach and determined its impact on subsequent infection during the pre-engraftment period. A single-center observational study was conducted, and surveillance cultures from multiple body sites, including the rectum, nasal cavity, and groin, were performed at admission to determine MDRO colonization. Serological tests were used to detect certain viruses and toxoplasmosis before HSCT. In the pre-transplant setting, 59 MDRO were recovered from the 40 HSCT recipients. Of the 59 isolates recovered from one or more body sites, 29 were positive for methicillin-resistant (MRSA), 7 for carbapenem-resistant Enterobacterales (CRE), and 23 were positive for extended-spectrum β-lactamase (ESBLs). Serological assessment before HSCT revealed active or reactivation of latent infection with cytomegalovirus (7.5%), Epstein-Barr virus (EBV; 5%), and (2.5%) among HSCT patients. In terms of factors associated with pre-engraftment infections, the type of transplant ( =0.04) was statistically significant, whereas other factors, such as age, sex, and underlying conditions, were not. In post-transplant settings, bloodstream infections (BSIs) were documented in 2 allogeneic HSCT patients (5%), and the isolated microorganisms were ESBL-producing and non-MDR . Active screening cultures are a helpful tool for identifying patients colonized by MDRO or relevant viruses before HSCT, and for predicting those at risk of developing subsequent pre-engraftment infections. Additionally, active screening may aid in predicting those who are likely to develop subsequent pre-engraftment infections Our findings highlight the importance of pre-transplant screening for high-priority multidrug-resistant pathogens and the application of infection control interventions after HSCT.